Zimmer (NYSE:ZMH), who acquired Biomet in a deal that closed this month, announced a series of personnel shifts upon the closure of the merger. Zimmer CFO and senior veep James Crines has stepped down from his position to retire, effective August 3, to be replaced by former CFO and senior veep of BiometDaniel Florin, the company said. […]
Transgenomic Inc.
Bacterin Q1 sales bound 120 percent | Earnings roundup

MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
BioMimetic losses widen 60 percent | Earnings roundup




MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Clinical Data sheds last assets of genetics and testing business


Clinical Data Inc. (NSDQ:CLDA) offloaded its its Familion testing and pharmacogenomics biomarker assetts to molecular diagnostics developer Transgenomic Inc. (OTC:TBIO) for $15.4 million, primarily in cash and notes.
The assets represent the last unit of Newton, Mass.-based Clinical Data’s non-pharmaceutical business.
Earnings roundup: Pressure BioSciences boosts Q3 sales, cuts losses




Pressure BioSciences boosts Q3 sales, cuts losses
Pressure BioSciences Inc. (NSDQ:PBIO) reported a loss of $693,000, or 26 cents per share, on revenue of $372,000 during the three months ended Sept. 30. That compares with losses of about $776,000, or 35 cents per share, on revenue of $317,427 during the same period last year.